Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,353 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical utility of a serum biomarker panel in distinguishing prostate cancer from benign prostate hyperplasia.
Kiebish MA, Tekumalla P, Ravipaty S, Dobi A, Srivastava S, Wu W, Patil S, Friss T, Klotz A, Srinivasan A, Cullen J, Rosner IL, Ali A, Laszlo S, Petrovic M, Fleshner N, Garren J, Miller G, Mahaveer Chand N, Rodrigues LO, Granger E, Kellogg MD, Luan S, Diamandis E, Akmaev VR, Sarangarajan R, Bountra C, Freedland SJ, McLeod DG, Narain NR. Kiebish MA, et al. Among authors: patil s. Sci Rep. 2021 Jul 23;11(1):15052. doi: 10.1038/s41598-021-94438-4. Sci Rep. 2021. PMID: 34302010 Free PMC article.
Diablo ubiquitination analysis by sandwich immunoassay.
Guven A, Wu WS, Patil S, Gokul K, Tekumalla P, Sharma S, Diers A, Gesta S, Vishnudas V, Sarangarajan R, Kellogg MD, Narain NR, Kiebish MA. Guven A, et al. Among authors: patil s. J Pharm Biomed Anal. 2019 Sep 5;173:40-46. doi: 10.1016/j.jpba.2019.05.005. Epub 2019 May 3. J Pharm Biomed Anal. 2019. PMID: 31108422
Leaping toward Tolerance.
Patil SU, Dougan SK, Dougan M. Patil SU, et al. NEJM Evid. 2024 Jun;3(6):EVIDe2400127. doi: 10.1056/EVIDe2400127. Epub 2024 May 28. NEJM Evid. 2024. PMID: 38804783 No abstract available.
Tafbromin selectively targets the TAF1 bromodomain.
Patil S, Cremosnik G, Dötsch L, Flegel J, Schulte B, Maier KC, Žumer K, Cramer P, Janning P, Sievers S, Ziegler S, Waldmann H. Patil S, et al. Angew Chem Int Ed Engl. 2024 May 27:e202404645. doi: 10.1002/anie.202404645. Online ahead of print. Angew Chem Int Ed Engl. 2024. PMID: 38801173
A Comparative Analysis of the Efficacy and Safety of Nimesulide/Paracetamol Fixed-Dose Combination With Other NSAIDs in Acute Pain Management: A Randomized, Prospective, Multicenter, Active-Controlled Study (the SAFE-2 Study).
Patil S, Nadaf N, Gupta S, Barai P, Makhija S, Lodha P, Patel C, Gondane AA, Pawar D, Sharma A. Patil S, et al. Cureus. 2024 Apr 23;16(4):e58859. doi: 10.7759/cureus.58859. eCollection 2024 Apr. Cureus. 2024. PMID: 38800230 Free PMC article.
Rational Drug Discovery for Isoxazole Based VEGFR2 Inhibition.
Patil SM, Mahadik I, Bhandari SV, Asgaonkar KD, Randive VD, Edake AM. Patil SM, et al. Curr Drug Discov Technol. 2024 May 24. doi: 10.2174/0115701638296906240522072628. Online ahead of print. Curr Drug Discov Technol. 2024. PMID: 38798213
5,353 results